Theravance Biopharma (TBPH) Sales of Property, Plant and Equipment (2018 - 2023)

Theravance Biopharma (TBPH) Sales of Property, Plant and Equipment (2018 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Theravance Biopharma 864.82 Mn 470.15 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 1.30 Mn
Jun 30, 2023 1.30 Mn
Mar 31, 2023 210,000.00
Mar 31, 2023 210,000.00
Jun 30, 2022 17,000.00
Jun 30, 2022 17,000.00
Mar 31, 2022 1.85 Mn
Mar 31, 2022 1.85 Mn
Dec 31, 2020 29,000.00
Dec 31, 2020 29,000.00
Sep 30, 2020 34,000.00
Sep 30, 2020 34,000.00
Mar 31, 2018 17,000.00
Mar 31, 2018 17,000.00